We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Automated Urine Analyzer And Components Evaluated

By LabMedica International staff writers
Posted on 15 Oct 2019
Print article
Image: The cobas 6500 urine analyzer series is a fully automated work area solution designed for laboratories that process 100 – 500 urine samples per day (Photo courtesy of Roche Diagnostics).
Image: The cobas 6500 urine analyzer series is a fully automated work area solution designed for laboratories that process 100 – 500 urine samples per day (Photo courtesy of Roche Diagnostics).
Urinalysis is a very common technique used in clinical practice, providing crucial information on the functioning of the kidneys and other organ systems, and aiding clinical decision-making in various diseases, such as diabetes, glomerulonephritis, and suspected urinary tract infections.

Automated urine analyzers systems offer practicable and faster urine screening, which may prevent unnecessary culture requests. The increased throughput of these instruments over manual methods enables the reliable and rapid screening of urine samples with reduced labor demands on laboratory staff, thereby improving efficiency and cost-effectiveness.

Clinical chemists at the Leiden University Medical Center (Leiden, The Netherlands) and their colleagues conducted a study at three European centers using un-centrifuged surplus routine urine samples; all measurements were performed within 2 hours of sample collection. Precision, sample carry-over and method comparisons were evaluated per Clinical and Laboratory Standards Institute guidelines.

The scientists compared the fully automated urine analyzer, the cobas u 601 versus the Roche Urisys 2400 and the Roche cobas u 411 urine test strips; and the Roche cobas u 701 versus KOVA visual microscopy and the iQ200 analyzer. Operability and functionality were assessed using questionnaires.

The team reported that precision of the entire cobas 6500 system was within predefined acceptance limits and no significant carry-over was observed. Erythrocytes, leukocytes, nitrites, and protein were in good agreement (≥93%) with cobas u 411 reflectometry. High correlation was shown between the cobas u 701 analyzer and KOVA visual microscopy for red blood cells (RBC) and white blood cells (WBC), demonstrating equivalence of test results. The 97.5% percentile reference values on the cobas u 701 analyzer were 5.3 cells/μL (RBC) and 6.2 cells/μL (WBC). The cobas 6500 system showed good sensitivity for small bacteria (>1 μm) and pathological casts, and the user interface, maintenance wizards and system design were highly rated by operators.

The authors concluded that showed that the fully automated cobas 6500 urine work area meets the analytical quality specifications recommended by European urinalysis guidelines, produces results comparable to those obtained by manual microscopy, and is suitable for routine clinical laboratory use. The study was published on September 19, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Leiden University Medical Center

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.